Morphine Completed Phase 4 Trials for Dyspnea / Morphine / Interstitial Lung Disease (ILD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02622022Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease